The Serum Institute has said that they will spend ₹40Cr to make Covid-19 medicine with 50Lakh potential doses a month


Serum Institute is owned by the Indian billionaire Cyrus Poonawalla, is planning to make the vaccine at its two manufacturing plants in India. Over roughly the next five months, Serum will spend some 30 Cr to 40 Cr rupees on making around 3-5 lakh doses per month.

The serum also shares its partnership with the U.S. biotech firm Codagenix and Austria’s Themis on two other COVID-19 vaccine candidates.

The success vaccination remains the Oxford vaccine, called “ChAdOx1 nCoV-19″, which is yet to be proven to work against COVID-19 but it had shown success in animal trials and had progressed to tests on humans.

Poonawalla said he trials of the Oxford vaccine may finish in September but the situation will remain quite stressful as it will ascertain not only whether the vaccine worked but that it induced good immune responses and no unacceptable side effects.

He also assured “a majority of the vaccine, at least initially, would have to go to our countrymen before it goes abroad,” adding that Serum would leave it to the Indian government to decide which countries would get how much of the vaccine and when. He also claimed that Prime Minister Narendra Modi’s office is “very closely” involved in the vaccine production.


Also read:-Three Senior IRS officers suspended for getting their Juniors to prepare a report for tax increase up to 40%

Also read:- BRICS have decided to create a $15 Billion fund for Nations to overcome Covid 19 impact

Also read:-Asian Development Bank (ADB) approves $1.5B loan for India to fight COVID-19

Jyotika Kumari
Content Writer +Creative Writer +Social Media Manager so basically I get you Up 2 Date.